1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting
Methodology
2.6.
Data
Triangulation & Validation
2.7.
Assumptions
and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global In-vitro
Diagnostics Enzymes Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1.
By Enzyme Type (Polymerase & Transcriptase, Proteases)
5.2.2.
By Disease Type (Infectious disease, Diabetes, Oncology,
Cardiology, Nephrology, Autoimmune diseases, Others)
5.2.3.
By Technology Type (Histology Assays, Molecular
Diagnostics, Clinical Chemistry)
5.2.4.
By End-Use (Pharmaceutical and Biopharmaceutical
Companies, Academic and Research Institutes, Others)
5.2.5.
By Region
5.2.6. By Company (2023)
5.3.
Market Map
5.3.1. By Enzyme Type
5.3.2. By Disease Type
5.3.3. By Technology Type
5.3.4. By End-Use
5.3.5. By Region
6. Asia Pacific
In-vitro Diagnostics Enzymes Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Enzyme Type
6.2.2. By Disease Type
6.2.3. By Technology Type
6.2.4. By End-Use
6.2.5. By Country
6.3.
Asia Pacific: Country Analysis
6.3.1. China In-vitro
Diagnostics Enzymes Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Enzyme Type
6.3.1.2.2.
By Disease Type
6.3.1.2.3.
By Technology Type
6.3.1.2.4.
By End-Use
6.3.2. India In-vitro
Diagnostics Enzymes Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Enzyme Type
6.3.2.2.2.
By Disease Type
6.3.2.2.3.
By Technology Type
6.3.2.2.4.
By End-Use
6.3.3. Australia In-vitro
Diagnostics Enzymes Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Enzyme Type
6.3.3.2.2.
By Disease Type
6.3.3.2.3.
By Technology Type
6.3.3.2.4.
By End-Use
6.3.4. Japan In-vitro
Diagnostics Enzymes Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Enzyme Type
6.3.4.2.2.
By Disease Type
6.3.4.2.3.
By Technology Type
6.3.4.2.4.
By End-Use
6.3.5. South Korea In-vitro
Diagnostics Enzymes Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Enzyme Type
6.3.5.2.2.
By Disease Type
6.3.5.2.3.
By Technology Type
6.3.5.2.4.
By End-Use
7. Europe In-vitro
Diagnostics Enzymes Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Enzyme Type
7.2.2. By Disease Type
7.2.3. By Technology Type
7.2.4. By
End-Use
7.2.5. By
Country
7.3.
Europe: Country Analysis
7.3.1. France In-vitro
Diagnostics Enzymes Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Enzyme Type
7.3.1.2.2.
By Disease Type
7.3.1.2.3.
By Technology Type
7.3.1.2.4.
By End-Use
7.3.2. Germany In-vitro
Diagnostics Enzymes Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Enzyme Type
7.3.2.2.2.
By Disease Type
7.3.2.2.3.
By Technology Type
7.3.2.2.4.
By End-Use
7.3.3. Spain In-vitro
Diagnostics Enzymes Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Enzyme Type
7.3.3.2.2.
By Disease Type
7.3.3.2.3.
By Technology Type
7.3.3.2.4.
By End-Use
7.3.4. Italy In-vitro
Diagnostics Enzymes Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Enzyme Type
7.3.4.2.2.
By Disease Type
7.3.4.2.3.
By Technology Type
7.3.4.2.4.
By End-Use
7.3.5. United Kingdom
In-vitro Diagnostics Enzymes Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Enzyme Type
7.3.5.2.2.
By Disease Type
7.3.5.2.3.
By Technology Type
7.3.5.2.4.
By End-Use
8. North America
In-vitro Diagnostics Enzymes Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Enzyme Type
8.2.2. By Disease Type
8.2.3. By Technology Type
8.2.4. By End-Use
8.2.5. By Country
8.3.
North America: Country Analysis
8.3.1. United States
In-vitro Diagnostics Enzymes Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Enzyme Type
8.3.1.2.2.
By Disease Type
8.3.1.2.3.
By Technology Type
8.3.1.2.4.
By End-Use
8.3.2. Mexico In-vitro
Diagnostics Enzymes Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Enzyme Type
8.3.2.2.2.
By Disease Type
8.3.2.2.3.
By Technology Type
8.3.2.2.4.
By End-Use
8.3.3. Canada In-vitro
Diagnostics Enzymes Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Enzyme Type
8.3.3.2.2.
By Disease Type
8.3.3.2.3.
By Technology Type
8.3.3.2.4.
By End-Use
9. South America In-vitro
Diagnostics Enzymes Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1.
By Enzyme Type
9.2.2.
By Disease Type
9.2.3.
By Technology Type
9.2.4.
By End-Use
9.2.5. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil In-vitro
Diagnostics Enzymes Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Enzyme Type
9.3.1.2.2.
By Disease Type
9.3.1.2.3.
By Technology Type
9.3.1.2.4.
By End-Use
9.3.2. Argentina In-vitro
Diagnostics Enzymes Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Enzyme Type
9.3.2.2.2.
By Disease Type
9.3.2.2.3.
By Technology Type
9.3.2.2.4.
By End-Use
9.3.3. Colombia In-vitro
Diagnostics Enzymes Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Enzyme Type
9.3.3.2.2.
By Disease Type
9.3.3.2.3.
By Technology Type
9.3.3.2.4.
By End-Use
10. Middle East and
Africa In-vitro Diagnostics Enzymes Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1.
By Enzyme Type
10.2.2.
By Disease Type
10.2.3.
By Technology Type
10.2.4. By End-Use
10.2.5. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa
In-vitro Diagnostics Enzymes Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Enzyme Type
10.3.1.2.2.
By Disease Type
10.3.1.2.3.
By Technology Type
10.3.1.2.4.
By End-Use
10.3.2. Saudi Arabia
In-vitro Diagnostics Enzymes Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Enzyme Type
10.3.2.2.2.
By Disease Type
10.3.2.2.3.
By Technology Type
10.3.2.2.4.
By End-Use
10.3.3. UAE In-vitro
Diagnostics Enzymes Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Enzyme Type
10.3.3.2.2.
By Disease Type
10.3.3.2.3.
By Technology Type
10.3.3.2.4.
By End-Use
10.3.4. Egypt In-vitro Diagnostics
Enzymes Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Enzyme Type
10.3.4.2.2.
By Disease Type
10.3.4.2.3.
By Technology Type
10.3.4.2.4.
By End-Use
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13.
Global In-vitro Diagnostics Enzymes Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15.
Competitive Landscape
15.1.
Merck KGaA
15.1.1.
Business Overview
15.1.2.
Company Snapshot
15.1.3.
Products & Services
15.1.4.
Financials (In case of listed)
15.1.5.
Recent Developments
15.1.6.
SWOT Analysis
15.2. Codexis, Inc.
15.3. F. Hoffmann-La Roche
Ltd.
15.4. Amano Enzymes Inc.
15.5. Advanced Enzymes
Technologies Ltd.
15.6. Biocatalysts Ltd.
15.7. Amicogen Co. Ltd
15.8. Dyadic International
Inc
15.9. Baduhenna Topco Limited.
15.10. Thermo Fisher Scientific Inc.
16. Strategic Recommendations
17. About Us & Disclaimer